Back to Business

Alkermes narcolepsy drug shows positive phase 2 trial results

Business August 24, 2026 at 10:36 PM

Alkermes narcolepsy drug shows positive phase 2 trial results

Investing.com

Read at Investing.com

More Stories

Japan eyes tax breaks for non-core business sales in governance reform push, sources say

Japan eyes tax breaks for non-core business sales in governance reform push, sources say

🇺🇸 Investing.com 21m ago

Judge rejects First Brands’ plan to pay down debts by pursuing lawsuits

Judge rejects First Brands’ plan to pay down debts by pursuing lawsuits

🇺🇸 Investing.com 21m ago

FDA approves J&J’s Imaavy for rare blood disorder treatment

FDA approves J&J’s Imaavy for rare blood disorder treatment

🇺🇸 Investing.com 23m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play